நுகர்வோர் சுய பராமரிப்பு ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நுகர்வோர் சுய பராமரிப்பு ப்ராடக்ட்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நுகர்வோர் சுய பராமரிப்பு ப்ராடக்ட்ஸ் Today - Breaking & Trending Today

Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations


Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations
Consumer Transformation Nearing Completion Ahead of Schedule
Rx Transaction On-Track to Close in Q3 21; Rx Segment Now Reported in Discontinued Operations
2021 Guidance Reaffirmed
Share this article
Share this article
DUBLIN, May 11, 2021 /PRNewswire/  Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter of fiscal year 2021 ended April 3, 2021. The Consumer Self-Care Americas ( CSCA ) segment, the Consumer Self-Care International ( CSCI ) segment and Corporate are included in results from continuing operations. Financial results from the generic Rx pharmaceuticals business are reported as discontinued operations. All comparisons are against the prior-year fiscal first quarter, unless otherwise noted. ....

United States , Murrays Kessler , Digestive Health , Rosemont Pharmaceuticals , Care International , Company Form , Exchange Commission , While The Company , Care International Segment , Perrigo Company , Us Internal Revenue Service , Consumer Self Care Products , Consumer Self Care Americas , Consumer Self Care International , Consolidated Statements , Balance Sheets , Highlights From Continuing , Results From Continuing , Eastern European , Project Momentum , Segment Results From Continuing , Esomeprazole Mini , Personal Hygiene , Upper Respiratory , Sleep Aids , Oral Self Care ,

Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration


Share this article
Share this article
DUBLIN, March 1, 2021 /PRNewswire/  Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of
Consumer Self-Care Products, announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for total consideration of $1.55 billion, including $1.5 billion in cash, subject to customary adjustments. As part of the consideration, Altaris will also assume more than $50 million in potential R&D milestone payments and contingent purchase obligations with third-party Rx partners.
Perrigo CEO and President Murray S. Kessler commented, The sale of our Generic Rx business is the most impactful step in Perrigo s transformation plan. This transaction establishes Perrigo as a pure-play global consumer self-care company with industry leading fundamentals. Perrigo Consumer Self-Care will have a focused portfolio with over $4 billion in revenues focused on ....

United States , Cleary Gottlieb , Rosen Katz , George Aitken Davies , Garikai Nyaruwata , Murrays Kessler , Schiff Hardin , Generic Rx Pharmaceuticals , Perrigo Rx Pharmaceuticals , Exchange Commission , Company Form , While The Company , Altaris Capital Partners , Perrigo Company , Goldman Sachs Co , Us Internal Revenue Service , Consumer Self Care Products , President Murray , Consumer Self Care , Managing Director , Lead Left Arranger , Goldman Sachs , Affordable Self Care Products , Proposed Assessment , Revenue Service , United States Securities ,